Taysha Gene Therapies
TSHA
$2.57
Share price
-0.39%
Change (1 day)
261.97%
Change (1 year)
EPS for Taysha Gene Therapies (TSHA)
EPS in 2023 (TTM): -$2.29
According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is -$2.29. In 2022 the company made an earnings per share (EPS) of -$3.80 an increase over its 2021 EPS that were of -$4.63.
EPS history for Taysha Gene Therapies from 2020 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.29 | -39.74% |
| 2022 | -$3.80 | -17.93% |
| 2021 | -$4.63 | 69.11% |
| 2020 | -$2.74 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -4.80% | 🇺🇸 USA |